CoreAge Rx Review: The $99 Semaglutide Is a $1,188 Payment

It depends entirely on how long you commit, and the advertised number assumes you commit for a year. Read off CoreAge's own package selector on August 9, 2026: compounded semaglutide is $1,188 for twelve months ($99/mo), $714 for six ($119/mo), $399 for three ($133/mo), and $190 for one. Compounded tirzepatide is $1,788 for twelve ($149/mo), $1,074 for six ($179/mo), $589 for three ($196/mo), and $239 for one. The twelve-month figure is not a monthly bill — the checkout charges it as a single payment today. If you want one month of semaglutide with no commitment, the number is $190.

Two very different answers, and the gap between them is the whole review. Commit up front and semaglutide is $1,188 for the year and tirzepatide is $1,788 — genuinely cheap for this category, and the dose never changes the price. Buy month by month and it is twelve payments of $190 or $239, which is $2,280 and $2,868. So the twelve-month plan saves $1,092 on semaglutide and $1,080 on tirzepatide, and costs you the entire sum on day one against a prescription a doctor has not yet written.

No, and CoreAge says so in one place. The footnote on get.coreagerx.com/home35/ reads: "Prices shown are starting at, based on a 12-month plan paid in full." Its checkout backs that up — select the twelve-month semaglutide plan and the order summary reads "Your total $1,188.00", one charge, four shipments of three vials each across the year. The problem is not that CoreAge hides it; it is that three of its four price surfaces omit it. The product page at coreagerx.com/product/semaglutide says "Starting at $99 per month" and stops there.

Not on top, no, and this is the part CoreAge gets right. Its checkout itemises "Doctor Support & Monitoring" at $99 and "Delivery" at $40 and strikes both through at Free, so a one-month semaglutide order totals $190 and nothing else. Its FAQ is equally direct: "There are no membership fees, no auto-rebills, and no surprise charges." One caveat sits in the refund policy rather than at checkout — a $50 to $100 provider consultation fee is carved out of what you paid and made non-refundable. It is not an extra charge, but it does mean a cancelled order does not come back whole.

The discount is reversed on what you have already received. CoreAge's refund policy: "if you choose the 12-month plan for the discounted rate and then cancel after your first shipment, the discount no longer applies and you will be billed at the standard 3-month plan price for that shipment." A twelve-month semaglutide plan ships three vials at a time, so the first shipment is re-priced from $297 of your prepay to the three-month rate of $399. That is a modest clawback rather than a punitive one, but it means the product pages' "No long-term contracts" is describing the paperwork, not the pricing.

No, and it is built that way rather than merely promised. The package selector prices on two inputs — which compound and how many months — with no dose control anywhere on it, and each tile carries its own ceiling: any dose up to 2.5 mg/wk on semaglutide, up to 15 mg/wk on tirzepatide. CoreAge also holds the figure for refills, so the price you pick is the price you keep. For a drug you titrate upward over months, that removes the single biggest reason a quote in this category turns out to be wrong.

Everywhere except Louisiana and Mississippi. CoreAge publishes no coverage page, so this was established by entering all 51 options in its own step-4 state gate one at a time on August 9, 2026: 49 advance to the next question, and Louisiana and Mississippi both return "Sorry, we do not service your state" and refuse to continue. Washington, D.C. passes, which is unusual — most funnels in this category simply omit it. One inconsistency to know about: the checkout's shipping dropdown still lists both refused states, so the block lives in the intake rather than in the payment page.

Because CoreAge's model puts the charge first, and it is candid about why: "Payment locks in your pricing and places you in the pharmacy queue." If the provider declines, the FAQ promises a 100% refund and step 9 of the intake asks you to tick a box saying you understand you will get "a full refund if I'm not approved – no hassle". The refund policy on the same site says something narrower — the $50 to $100 consultation fee is non-refundable "even if… Your prescription is not approved". Both statements are published by CoreAge Rx. They cannot both be true, and the one you agreed to at checkout is not the one written into the policy.

Enough to be worth knowing before you read anything else on the page. The "SUMMER SALE" banner counts down from 2 hours 59 minutes and resets to 2 hours 59 minutes on every fresh session, so its deadline never arrives. The "Congratulations! You have been pre-approved for GLP-1 medication at the lowest pricing" screen renders with the stored intake object entirely blank — no age, no state, no medical history — so nothing was assessed. And the pop-up notices about other customers are a hard-coded array in the page's own JavaScript: roughly seventy invented names, cities, pound counts and plan choices, cycling on a timer. None of this touches the prices, which check out exactly as advertised once you know what "$99" means. It does mean the urgency around them is manufactured.

No. FDA's live warning-letter index was queried on August 9, 2026 for "coreage", "coreagerx", "coreage rx", and for the parent company both spaced and condensed — "fine shrimp" and "dso fine shrimp". All five returned zero records with no truncation. A query for "skinnyrx" run in the same pass returned that company's February 20, 2026 letter, which is what makes the zeros above mean something rather than merely indicating a query that does not work. For context, several of the largest compounded-GLP-1 sellers do carry letters, almost always about how a vial is labelled rather than what is in it.